Outset Medical (OM) Non-Current Deffered Revenue (2019 - 2026)
Outset Medical has reported Non-Current Deffered Revenue over the past 7 years, most recently at $406000.0 for Q4 2025.
- Quarterly Non-Current Deffered Revenue fell 51.9% to $406000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $406000.0 through Dec 2025, down 51.9% year-over-year, with the annual reading at $406000.0 for FY2025, 51.9% down from the prior year.
- Non-Current Deffered Revenue was $406000.0 for Q4 2025 at Outset Medical, down from $676000.0 in the prior quarter.
- Over five years, Non-Current Deffered Revenue peaked at $844000.0 in Q4 2024 and troughed at $77000.0 in Q3 2024.
- The 5-year median for Non-Current Deffered Revenue is $190000.0 (2022), against an average of $313950.0.
- Year-over-year, Non-Current Deffered Revenue crashed 80.74% in 2021 and then surged 777.92% in 2025.
- A 5-year view of Non-Current Deffered Revenue shows it stood at $312000.0 in 2021, then tumbled by 51.6% to $151000.0 in 2022, then plummeted by 33.11% to $101000.0 in 2023, then surged by 735.64% to $844000.0 in 2024, then crashed by 51.9% to $406000.0 in 2025.
- Per Business Quant, the three most recent readings for OM's Non-Current Deffered Revenue are $406000.0 (Q4 2025), $676000.0 (Q3 2025), and $587000.0 (Q2 2025).